iShares Trust (IBB)
Management Company · XNAS · Series S000004350 · View on SEC EDGAR ↗
$210.83
As of Aug. 20, 2026
▼ -6.13 (-2.83%)
1-day change
$136.89 – $217.06
52-week range
+0.02%
Premium / Discount
NAV as of Aug. 19, 2026
Feb. 5, 2001
Inception
Net flows (30d): +$37.5M Estimated from creation/redemption of shares outstanding
- Net assets
- $10.2B
- Holdings
- 252
- As of
- Aug. 18, 2026
- Expense ratio
- 0.44% (Moderate)
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Recent changes Positions the fund added, trimmed or exited most recently.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
IBB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of Aug. 20, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +14.34% | — |
| 3M | ▲ +27.01% | — |
| 6M | ▲ +22.29% | — |
| YTD | ▲ +26.37% | — |
| 1Y | ▲ +54.07% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▲ +51.37% | — |
- Volatility 1Y
- 21.42%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- 0.41
- Sharpe 1Y*
- 2.13
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Mar 2026)
- -$332.0M
- Quarter ending Mar 2026
- -$208.5M
- Trailing 12 months
- +$630.9M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 252 holdings
| Issuer | Ticker | Weight % | Market value | Shares | CUSIP | Units/share | Type | Currency |
|---|---|---|---|---|---|---|---|---|
| XENCOR | XNCR | 0.13 | ≈$13.3M | 520,546 | 98401F105 | 0.01042 | EQUITY | USD |
| NOVOCURE | NVCR | 0.13 | ≈$13.2M | 779,742 | JE00BYSS4X48 | 0.01561 | EQUITY | USD |
| VERA THERAPEUTICS CLASS A | VERA | 0.13 | ≈$13.1M | 435,693 | 92337R101 | 0.008723 | EQUITY | USD |
| AURINIA PHARMACEUTICALS | AUPH | 0.13 | ≈$12.8M | 850,131 | 05156V102 | 0.01702 | EQUITY | USD |
| GRIFOLS ADR REPRESENTING ONE NON-V | GRFS | 0.12 | ≈$12.7M | 1,648,137 | 398438408 | 0.033 | EQUITY | USD |
| NUVATION BIO CLASS A | NUVB | 0.12 | ≈$12.5M | 1,851,279 | 67080N101 | 0.03706 | EQUITY | USD |
| BIOHAVEN | BHVN | 0.12 | ≈$12.3M | 936,854 | VGG1110E1079 | 0.01876 | EQUITY | USD |
| SUMMIT THERAPEUTICS | SMMT | 0.12 | ≈$12.3M | 1,005,912 | 86627T108 | 0.02014 | EQUITY | USD |
| INTELLIA THERAPEUTICS | NTLA | 0.12 | ≈$12.2M | 987,815 | 45826J105 | 0.01978 | EQUITY | USD |
| TREVI THERAPEUTICS | TRVI | 0.12 | ≈$12.1M | 692,559 | 89532M101 | 0.01387 | EQUITY | USD |
| FORTREA HOLDINGS INC | FTRE | 0.12 | ≈$11.9M | 704,274 | 34965K107 | 0.0141 | EQUITY | USD |
| TAYSHA GENE THERAPIES | TSHA | 0.12 | ≈$11.9M | 1,984,991 | 877619106 | 0.03974 | EQUITY | USD |
| SYNDAX PHARMACEUTICALS | SNDX | 0.11 | ≈$11.6M | 601,570 | 87164F105 | 0.01204 | EQUITY | USD |
| RECURSION PHARMACEUTICALS CLASS A | RXRX | 0.11 | ≈$11.4M | 3,511,701 | 75629V104 | 0.0703 | EQUITY | USD |
| MINERALYS THERAPEUTICS | MLYS | 0.11 | ≈$11.4M | 453,818 | 603170101 | 0.009085 | EQUITY | USD |
| STOKE THERAPEUTICS | STOK | 0.11 | ≈$11.3M | 368,262 | 86150R107 | 0.007373 | EQUITY | USD |
| ANAPTYSBIO | ANAB | 0.11 | ≈$11.2M | 203,628 | 032724106 | 0.004077 | EQUITY | USD |
| IMMUNOCORE HOLDINGS ADR PLC | IMCR | 0.11 | ≈$10.9M | 317,670 | 45258D105 | 0.00636 | EQUITY | USD |
| COMPASS PATHWAYS ADR PLC | CMPS | 0.10 | ≈$10.6M | 812,518 | 20451W101 | 0.01627 | EQUITY | USD |
| GH RESEARCH PLC | GHRS | 0.10 | ≈$10.1M | 363,992 | IE000GID8VI0 | 0.007287 | EQUITY | USD |
| RAPPORT THERAPEUTICS | RAPP | 0.10 | ≈$9.8M | 213,475 | 75383L102 | 0.004274 | EQUITY | USD |
| NOVAVAX | NVAX | 0.09 | ≈$9.6M | 1,168,796 | 670002401 | 0.0234 | EQUITY | USD |
| ABSCI CORP | ABSI | 0.09 | ≈$9.3M | 1,003,280 | 00091E109 | 0.02009 | EQUITY | USD |
| VIR BIOTECHNOLOGY | VIR | 0.09 | ≈$9.1M | 998,808 | 92764N102 | 0.02 | EQUITY | USD |
| MANNKIND | MNKD | 0.09 | ≈$9.0M | 2,209,665 | 56400P706 | 0.04424 | EQUITY | USD |
| ALTO NEUROSCIENCE INC | ANRO | 0.08 | ≈$8.5M | 263,147 | 02157Q109 | 0.005268 | EQUITY | USD |
| LAKEFRONT BIOTHERAPEUTICS ADR NV | LKFT | 0.08 | ≈$8.5M | 311,060 | 36315X101 | 0.006227 | EQUITY | USD |
| SEPTERNA | SEPN | 0.08 | ≈$8.4M | 205,741 | 81734D104 | 0.004119 | EQUITY | USD |
| MESOBLAST ADR REPRESENTING | MESO | 0.08 | ≈$8.4M | 526,575 | 590717401 | 0.01054 | EQUITY | USD |
| TYRA BIOSCIENCES | TYRA | 0.08 | ≈$8.3M | 330,973 | 90240B106 | 0.006626 | EQUITY | USD |
| REPLIMUNE GROUP | REPL | 0.08 | ≈$7.9M | 575,841 | 76029N106 | 0.01153 | EQUITY | USD |
| PRECIGEN | PGEN | 0.08 | ≈$7.8M | 1,175,272 | 74017N105 | 0.02353 | EQUITY | USD |
| INHIBRX BIOSCIENCES INC | INBX | 0.08 | ≈$7.7M | 81,682 | 45720N103 | 0.001635 | EQUITY | USD |
| KURA ONCOLOGY | KURA | 0.07 | ≈$7.5M | 646,458 | 50127T109 | 0.01294 | EQUITY | USD |
| STEVANATO GROUP | STVN | 0.07 | ≈$7.5M | 370,500 | IT0005452658 | 0.007417 | EQUITY | USD |
| MEIRAGTX HOLDINGS PLC | MGTX | 0.07 | ≈$7.4M | 528,165 | KYG596651029 | 0.01057 | EQUITY | USD |
| PHARVARIS N V | PHVS | 0.07 | ≈$7.4M | 218,152 | NL00150005Y4 | 0.004367 | EQUITY | USD |
| MAZE THERAPEUTICS | MAZE | 0.07 | ≈$7.2M | 258,927 | 578784100 | 0.005184 | EQUITY | USD |
| CULLINAN THERAPEUTICS | CGEM | 0.07 | ≈$7.0M | 335,905 | 230031106 | 0.006725 | EQUITY | USD |
| JANUX THERAPEUTICS | JANX | 0.07 | ≈$7.0M | 430,715 | 47103J105 | 0.008623 | EQUITY | USD |
| GERON | GERN | 0.07 | ≈$7.0M | 4,724,693 | 374163103 | 0.09459 | EQUITY | USD |
| ZENAS BIOPHARMA | ZBIO | 0.07 | ≈$7.0M | 239,528 | 98937L105 | 0.004795 | EQUITY | USD |
| ARRIVENT BIOPHARMA | AVBP | 0.07 | ≈$6.9M | 245,411 | 04272N102 | 0.004913 | EQUITY | USD |
| PERSONALIS | PSNL | 0.07 | ≈$6.9M | 466,042 | 71535D106 | 0.00933 | EQUITY | USD |
| CORVUS PHARMACEUTICALS | CRVS | 0.07 | ≈$6.8M | 475,571 | 221015100 | 0.009521 | EQUITY | USD |
| BICARA THERAPEUTICS INC | BCAX | 0.07 | ≈$6.8M | 282,230 | 055477103 | 0.00565 | EQUITY | USD |
| CASTLE BIOSCIENCES | CSTL | 0.07 | ≈$6.7M | 223,053 | 14843C105 | 0.004466 | EQUITY | USD |
| MONTE ROSA THERAPEUTICS | GLUE | 0.06 | ≈$6.5M | 440,602 | 61225M102 | 0.008821 | EQUITY | USD |
| ORIC PHARMACEUTICALS | ORIC | 0.06 | ≈$6.3M | 462,034 | 68622P109 | 0.00925 | EQUITY | USD |
| WAVE LIFE SCIENCES INC | WVE | 0.06 | ≈$6.0M | 1,180,055 | 94352A104 | 0.02362 | EQUITY | USD |
Market value is estimated from each holding's weight and the fund's net assets. Weight and shares are as reported by the fund.
Page 3
of 6
Sector breakdown
Healthcare
99.5%
Other/Unmapped
0.5%
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Aug. 19, 2026 | Increased |
AARD — AARDVARK THERAPEUTICS
002942100
|
Units/share: 0.001864 → 0.001877 (0.7%) |
| Aug. 19, 2026 | Increased |
ABCL — ABCELLERA BIOLOGICS
00288U106
|
Units/share: 0.03499 → 0.0352 (0.6%) |
| Aug. 19, 2026 | Increased |
ABSI — ABSCI CORP
00091E109
|
Units/share: 0.01997 → 0.02009 (0.6%) |
| Aug. 19, 2026 | Increased |
ABUS — ARBUTUS BIOPHARMA CORP
03879J100
|
Units/share: 0.02359 → 0.02373 (0.6%) |
| Aug. 19, 2026 | Increased |
ABVX — ABIVAX AMERICAN DEPOSITARY SHARES
00370M103
|
Units/share: 0.009647 → 0.009705 (0.6%) |
| Aug. 19, 2026 | Increased |
ACAD — ACADIA PHARMACEUTICALS
004225108
|
Units/share: 0.02511 → 0.02526 (0.6%) |
| Aug. 19, 2026 | Increased |
ACIU — AC IMMUNE SA
CH0329023102
|
Units/share: 0.009065 → 0.009119 (0.6%) |
| Aug. 19, 2026 | Increased |
ACRS — ACLARIS THERAPEUTICS
00461U105
|
Units/share: 0.0163 → 0.01639 (0.6%) |
| Aug. 19, 2026 | Increased |
ADCT — ADC THERAPEUTICS SA
CH0499880968
|
Units/share: 0.01401 → 0.01409 (0.6%) |
| Aug. 19, 2026 | Increased |
ADMA — ADMA BIOLOGICS
000899104
|
Units/share: 0.03348 → 0.03368 (0.6%) |
| Aug. 19, 2026 | Increased |
ADPT — ADAPTIVE BIOTECHNOLOGIES
00650F109
|
Units/share: 0.02302 → 0.02316 (0.6%) |
| Aug. 19, 2026 | Trimmed |
ADRO — CHINOOK THERAPEUTICS INC
169CVR016
|
Units/share: 0.006432 → 0.006426 (-0.1%) |
| Aug. 19, 2026 | Increased |
AGIO — AGIOS PHARMACEUTICALS
00847X104
|
Units/share: 0.008282 → 0.008332 (0.6%) |
| Aug. 19, 2026 | Trimmed |
AKE — AKERO THERAPEUTICS CVR
009CVR044
|
Units/share: 0.01034 → 0.01033 (-0.1%) |
| Aug. 19, 2026 | Increased |
ALKS — ALKERMES
IE00B56GVS15
|
Units/share: 0.02425 → 0.02439 (0.6%) |
| Aug. 19, 2026 | Increased |
ALLO — ALLOGENE THERAPEUTICS
019770106
|
Units/share: 0.03777 → 0.038 (0.6%) |
| Aug. 19, 2026 | Increased |
ALMS — ALUMIS
022307102
|
Units/share: 0.01244 → 0.01252 (0.6%) |
| Aug. 19, 2026 | Increased |
ALNY — ALNYLAM PHARMACEUTICALS
02043Q107
|
Units/share: 0.01978 → 0.0199 (0.6%) |
| Aug. 19, 2026 | Increased |
ALT — ALTIMMUNE INC
02155H200
|
Units/share: 0.02713 → 0.0273 (0.6%) |
| Aug. 19, 2026 | Increased |
ALVO — ALVOTECH SA
LU2458332611
|
Units/share: 0.02089 → 0.02102 (0.6%) |
| Aug. 19, 2026 | Increased |
AMGN — AMGEN INC
031162100
|
Units/share: 0.04125 → 0.0415 (0.6%) |
| Aug. 19, 2026 | Increased |
AMLX — AMYLYX PHARMACEUTICALS
03237H101
|
Units/share: 0.01379 → 0.01387 (0.6%) |
| Aug. 19, 2026 | Increased |
ANAB — ANAPTYSBIO
032724106
|
Units/share: 0.004048 → 0.004077 (0.7%) |
| Aug. 19, 2026 | Increased |
ANNX — ANNEXON
03589W102
|
Units/share: 0.02146 → 0.02159 (0.6%) |
| Aug. 19, 2026 | Increased |
ANRO — ALTO NEUROSCIENCE INC
02157Q109
|
Units/share: 0.005237 → 0.005268 (0.6%) |
| Aug. 19, 2026 | Increased |
APGE — APOGEE THERAPEUTICS
03770N101
|
Units/share: 0.008474 → 0.008524 (0.6%) |
| Aug. 19, 2026 | Increased |
ARCT — ARCTURUS THERAPEUTICS HOLDINGS INC
03969T109
|
Units/share: 0.003848 → 0.003871 (0.6%) |
| Aug. 19, 2026 | Increased |
ARGX — ARGENX SE ADR
04016X101
|
Units/share: 0.007731 → 0.007777 (0.6%) |
| Aug. 19, 2026 | Increased |
ARQT — ARCUTIS BIOTHERAPEUTICS
03969K108
|
Units/share: 0.01646 → 0.01656 (0.6%) |
| Aug. 19, 2026 | Increased |
ARVN — ARVINAS INC
04335A105
|
Units/share: 0.008033 → 0.008081 (0.6%) |
| Aug. 19, 2026 | Increased |
ARWR — ARROWHEAD PHARMACEUTICALS
04280A100
|
Units/share: 0.01969 → 0.01981 (0.6%) |
| Aug. 19, 2026 | Increased |
ASND — ASCENDIS PHARMA
DK0060615755
|
Units/share: 0.0092 → 0.009255 (0.6%) |
| Aug. 19, 2026 | Increased |
ATAI — ATAIBECKLEY INC
04650F101
|
Units/share: 0.04379 → 0.04406 (0.6%) |
| Aug. 19, 2026 | Increased |
AUPH — AURINIA PHARMACEUTICALS
05156V102
|
Units/share: 0.01692 → 0.01702 (0.6%) |
| Aug. 19, 2026 | Increased |
AURA — AURA BIOSCIENCES
05153U107
|
Units/share: 0.009549 → 0.009606 (0.6%) |
| Aug. 19, 2026 | Increased |
AUTL — AUTOLUS THERAPEUTICS ADR PLC
05280R100
|
Units/share: 0.02992 → 0.0301 (0.6%) |
| Aug. 19, 2026 | Increased |
AVBP — ARRIVENT BIOPHARMA
04272N102
|
Units/share: 0.004884 → 0.004913 (0.6%) |
| Aug. 19, 2026 | Increased |
AVIR — ATEA PHARMACEUTICALS
04683R106
|
Units/share: 0.009568 → 0.009626 (0.6%) |
| Aug. 19, 2026 | Increased |
AVXL — ANAVEX LIFE SCIENCES CORP
032797300
|
Units/share: 0.01323 → 0.01331 (0.6%) |
| Aug. 19, 2026 | Increased |
AXSM — AXSOME THERAPEUTICS
05464T104
|
Units/share: 0.006408 → 0.006446 (0.6%) |
| Aug. 19, 2026 | Increased |
BBIO — BRIDGEBIO PHARMA
10806X102
|
Units/share: 0.02516 → 0.02531 (0.6%) |
| Aug. 19, 2026 | Increased |
BBOT — BRIDGEBIO ONCOLOGY THERAPEUTICS IN
107924102
|
Units/share: 0.006408 → 0.006447 (0.6%) |
| Aug. 19, 2026 | Increased |
BCAX — BICARA THERAPEUTICS INC
055477103
|
Units/share: 0.005616 → 0.00565 (0.6%) |
| Aug. 19, 2026 | Increased |
BCRX — BIOCRYST PHARMACEUTICALS
09058V103
|
Units/share: 0.03202 → 0.03221 (0.6%) |
| Aug. 19, 2026 | Increased |
BCYC — BICYCLE THERAPEUTICS ADR PLC
088786108
|
Units/share: 0.005528 → 0.005561 (0.6%) |
| Aug. 19, 2026 | Increased |
BDTX — BLACK DIAMOND THERAPEUTICS INC
09203E105
|
Units/share: 0.007269 → 0.007313 (0.6%) |
| Aug. 19, 2026 | Increased |
BEAM — BEAM THERAPEUTICS
07373V105
|
Units/share: 0.01398 → 0.01406 (0.6%) |
| Aug. 19, 2026 | Increased |
BHVN — BIOHAVEN
VGG1110E1079
|
Units/share: 0.01864 → 0.01876 (0.6%) |
| Aug. 19, 2026 | Increased |
BIIB — BIOGEN
09062X103
|
Units/share: 0.02178 → 0.02191 (0.6%) |
| Aug. 19, 2026 | Increased |
BIOA — BIOAGE LABS
09077V100
|
Units/share: 0.004677 → 0.004706 (0.6%) |
| Aug. 19, 2026 | Increased |
BMRN — BIOMARIN PHARMACEUTICAL
09061G101
|
Units/share: 0.02832 → 0.02849 (0.6%) |
| Aug. 19, 2026 | Increased |
BNTX — BIONTECH SE ADR
09075V102
|
Units/share: 0.01361 → 0.01369 (0.6%) |
| Aug. 19, 2026 | Increased |
BRKR — BRUKER
116794108
|
Units/share: 0.01653 → 0.01663 (0.6%) |
| Aug. 19, 2026 | Increased |
CABA — CABALETTA BIO
12674W109
|
Units/share: 0.02109 → 0.02122 (0.6%) |
| Aug. 19, 2026 | Increased |
CADL — CANDEL THERAPEUTICS INC
137404109
|
Units/share: 0.008596 → 0.008648 (0.6%) |
| Aug. 19, 2026 | Increased |
CAI — CARIS LIFE SCIENCES
142152107
|
Units/share: 0.01819 → 0.0183 (0.6%) |
| Aug. 19, 2026 | Increased |
CATX — PERSPECTIVE THERAPEUTICS INC
46489V302
|
Units/share: 0.01332 → 0.0134 (0.6%) |
| Aug. 19, 2026 | Increased |
CCCC — C4 THERAPEUTICS
12529R107
|
Units/share: 0.01481 → 0.0149 (0.6%) |
| Aug. 19, 2026 | Increased |
CDNA — CAREDX
14167L103
|
Units/share: 0.006949 → 0.006991 (0.6%) |
| Aug. 19, 2026 | Increased |
CDXS — CODEXIS
192005106
|
Units/share: 0.01243 → 0.01251 (0.6%) |
| Aug. 19, 2026 | Increased |
CGEM — CULLINAN THERAPEUTICS
230031106
|
Units/share: 0.006685 → 0.006725 (0.6%) |
| Aug. 19, 2026 | Increased |
CGON — CG ONCOLOGY
156944100
|
Units/share: 0.008565 → 0.008617 (0.6%) |
| Aug. 19, 2026 | Increased |
CLLS — CELLECTIS ADR REPRESENTING SA
15117K103
|
Units/share: 0.004672 → 0.0047 (0.6%) |
| Aug. 19, 2026 | Increased |
CMPS — COMPASS PATHWAYS ADR PLC
20451W101
|
Units/share: 0.01617 → 0.01627 (0.6%) |
| Aug. 19, 2026 | Increased |
COGT — COGENT BIOSCIENCES
19240Q201
|
Units/share: 0.02187 → 0.022 (0.6%) |
| Aug. 19, 2026 | Increased |
CRBU — CARIBOU BIOSCIENCES
142038108
|
Units/share: 0.01316 → 0.01324 (0.6%) |
| Aug. 19, 2026 | Trimmed |
CRGX — CARGO THERAPEUTICS INC
141CVR019
|
Units/share: 0.00397 → 0.003966 (-0.1%) |
| Aug. 19, 2026 | Increased |
CRL — CHARLES RIVER LABORATORIES INTERNA
159864107
|
Units/share: 0.007082 → 0.007124 (0.6%) |
| Aug. 19, 2026 | Increased |
CRNX — CRINETICS PHARMACEUTICALS
22663K107
|
Units/share: 0.01456 → 0.01464 (0.6%) |
| Aug. 19, 2026 | Increased |
CRSP — CRISPR THERAPEUTICS AG
CH0334081137
|
Units/share: 0.01334 → 0.01342 (0.6%) |
| Aug. 19, 2026 | Increased |
CRVS — CORVUS PHARMACEUTICALS
221015100
|
Units/share: 0.009464 → 0.009521 (0.6%) |
| Aug. 19, 2026 | Increased |
CSTL — CASTLE BIOSCIENCES
14843C105
|
Units/share: 0.004439 → 0.004466 (0.6%) |
| Aug. 19, 2026 | Increased |
CTKB — CYTEK BIOSCIENCES
23285D109
|
Units/share: 0.01745 → 0.01755 (0.6%) |
| Aug. 19, 2026 | Increased |
CTMX — CYTOMX THERAPEUTICS
23284F105
|
Units/share: 0.02468 → 0.02483 (0.6%) |
| Aug. 19, 2026 | Increased |
CTNM — CONTINEUM THERAPEUTICS INC CLASS A
21217B100
|
Units/share: 0.004297 → 0.004323 (0.6%) |
| Aug. 19, 2026 | Increased |
CYTK — CYTOKINETICS
23282W605
|
Units/share: 0.01773 → 0.01784 (0.6%) |
| Aug. 19, 2026 | Increased |
DFTX — DEFINIUM THERAPEUTICS INC
24477V105
|
Units/share: 0.01895 → 0.01906 (0.6%) |
| Aug. 19, 2026 | Increased |
DNA — GINKGO BIOWORKS HOLDINGS CLASS A
37611X209
|
Units/share: 0.00746 → 0.007505 (0.6%) |
| Aug. 19, 2026 | Increased |
DNLI — DENALI THERAPEUTICS
24823R105
|
Units/share: 0.02217 → 0.0223 (0.6%) |
| Aug. 19, 2026 | Increased |
DSGN — DESIGN THERAPEUTICS
25056L103
|
Units/share: 0.005565 → 0.005598 (0.6%) |
| Aug. 19, 2026 | Increased |
DYN — DYNE THERAPEUTICS
26818M108
|
Units/share: 0.02228 → 0.02242 (0.6%) |
| Aug. 19, 2026 | Increased |
EBS — EMERGENT BIOSOLUTIONS
29089Q105
|
Units/share: 0.007195 → 0.007238 (0.6%) |
| Aug. 19, 2026 | Increased |
EDIT — EDITAS MEDICINE
28106W103
|
Units/share: 0.02097 → 0.0211 (0.6%) |
| Aug. 19, 2026 | Increased |
ELVN — ENLIVEN THERAPEUTICS
29337E102
|
Units/share: 0.008265 → 0.008314 (0.6%) |
| Aug. 19, 2026 | Increased |
ENTA — ENANTA PHARMACEUTICALS INC
29251M106
|
Units/share: 0.004078 → 0.004102 (0.6%) |
| Aug. 19, 2026 | Increased |
ERAS — ERASCA
29479A108
|
Units/share: 0.031 → 0.03119 (0.6%) |
| Aug. 19, 2026 | Increased |
EWTX — EDGEWISE THERAPEUTICS
28036F105
|
Units/share: 0.01169 → 0.01176 (0.6%) |
| Aug. 19, 2026 | Increased |
EXEL — EXELIXIS INC
30161Q104
|
Units/share: 0.03624 → 0.03646 (0.6%) |
| Aug. 19, 2026 | Increased |
FDMT — 4D MOLECULAR THERAPEUTICS INC
35104E100
|
Units/share: 0.00689 → 0.006931 (0.6%) |
| Aug. 19, 2026 | Increased |
FHTX — FOGHORN THERAPEUTICS
344174107
|
Units/share: 0.004645 → 0.004673 (0.6%) |
| Aug. 19, 2026 | Increased |
FLGT — FULGENT GENETICS
359664109
|
Units/share: 0.0027 → 0.002716 (0.6%) |
| Aug. 19, 2026 | Increased |
FTRE — FORTREA HOLDINGS INC
34965K107
|
Units/share: 0.01402 → 0.0141 (0.6%) |
| Aug. 19, 2026 | Increased |
FULC — FULCRUM THERAPEUTICS
359616109
|
Units/share: 0.008336 → 0.008386 (0.6%) |
| Aug. 19, 2026 | Increased |
GERN — GERON
374163103
|
Units/share: 0.09402 → 0.09459 (0.6%) |
| Aug. 19, 2026 | Increased |
GHRS — GH RESEARCH PLC
IE000GID8VI0
|
Units/share: 0.007244 → 0.007287 (0.6%) |
| Aug. 19, 2026 | Increased |
GILD — GILEAD SCIENCES INC
375558103
|
Units/share: 0.1033 → 0.104 (0.6%) |
| Aug. 19, 2026 | Increased |
GLUE — MONTE ROSA THERAPEUTICS
61225M102
|
Units/share: 0.008768 → 0.008821 (0.6%) |
| Aug. 19, 2026 | Increased |
GMAB — GENMAB SPONSORED ADR
372303206
|
Units/share: 0.07772 → 0.07818 (0.6%) |
| Aug. 19, 2026 | Increased |
GOSS — GOSSAMER BIO
38341P102
|
Units/share: 0.06653 → 0.06693 (0.6%) |
| Aug. 19, 2026 | Increased |
GPCR — STRUCTURE THERAPEUTICS ADR
86366E106
|
Units/share: 0.008716 → 0.008768 (0.6%) |
| Aug. 19, 2026 | Increased |
GRAL — GRAIL INC
384747101
|
Units/share: 0.00591 → 0.005945 (0.6%) |
| Aug. 19, 2026 | Increased |
GRFS — GRIFOLS ADR REPRESENTING ONE NON-V
398438408
|
Units/share: 0.0328 → 0.033 (0.6%) |
| Aug. 19, 2026 | Increased |
HALO — HALOZYME THERAPEUTICS
40637H109
|
Units/share: 0.01747 → 0.01757 (0.6%) |
| Aug. 19, 2026 | Increased |
HUMA — HUMACYTE INC
44486Q103
|
Units/share: 0.03636 → 0.03658 (0.6%) |
| Aug. 19, 2026 | Increased |
IBRX — IMMUNITYBIO INC
45256X103
|
Units/share: 0.05607 → 0.05641 (0.6%) |
| Aug. 19, 2026 | Increased |
IDYA — IDEAYA BIOSCIENCES
45166A102
|
Units/share: 0.01238 → 0.01246 (0.6%) |
| Aug. 19, 2026 | Increased |
ILMN — ILLUMINA INC
452327109
|
Units/share: 0.02245 → 0.02259 (0.6%) |
| Aug. 19, 2026 | Increased |
IMCR — IMMUNOCORE HOLDINGS ADR PLC
45258D105
|
Units/share: 0.006322 → 0.00636 (0.6%) |
| Aug. 19, 2026 | Increased |
IMMP — IMMUTEP ADS REPRESENTING LTD
45257L108
|
Units/share: 0.01536 → 0.01545 (0.6%) |
| Aug. 19, 2026 | Increased |
IMRX — IMMUNEERING CLASS A
45254E107
|
Units/share: 0.008508 → 0.008559 (0.6%) |
| Aug. 19, 2026 | Increased |
IMVT — IMMUNOVANT
45258J102
|
Units/share: 0.01206 → 0.01214 (0.6%) |
| Aug. 19, 2026 | Increased |
INBX — INHIBRX BIOSCIENCES INC
45720N103
|
Units/share: 0.001624 → 0.001635 (0.7%) |
| Aug. 19, 2026 | Increased |
INCY — INCYTE CORP
45337C102
|
Units/share: 0.02945 → 0.02963 (0.6%) |
| Aug. 19, 2026 | Increased |
INSM — INSMED
457669307
|
Units/share: 0.03194 → 0.03214 (0.6%) |
| Aug. 19, 2026 | Increased |
IONS — IONIS PHARMACEUTICALS
462222100
|
Units/share: 0.02411 → 0.02426 (0.6%) |
| Aug. 19, 2026 | Increased |
IOVA — IOVANCE BIOTHERAPEUTICS INC
462260100
|
Units/share: 0.05781 → 0.05815 (0.6%) |
| Aug. 19, 2026 | Increased |
IRON — DISC MEDICINE
254604101
|
Units/share: 0.004109 → 0.004133 (0.6%) |
| Aug. 19, 2026 | Increased |
IRWD — IRONWOOD PHARMA CLASS A
46333X108
|
Units/share: 0.02338 → 0.02352 (0.6%) |
| Aug. 19, 2026 | Increased |
JANX — JANUX THERAPEUTICS
47103J105
|
Units/share: 0.008572 → 0.008623 (0.6%) |
| Aug. 19, 2026 | Increased |
KOD — KODIAK SCIENCES
50015M109
|
Units/share: 0.008596 → 0.008648 (0.6%) |
| Aug. 19, 2026 | Increased |
KROS — KEROS THERAPEUTICS
492327101
|
Units/share: 0.002688 → 0.002707 (0.7%) |
| Aug. 19, 2026 | Increased |
KRYS — KRYSTAL BIOTECH
501147102
|
Units/share: 0.003828 → 0.003851 (0.6%) |
| Aug. 19, 2026 | Increased |
KURA — KURA ONCOLOGY
50127T109
|
Units/share: 0.01286 → 0.01294 (0.6%) |
| Aug. 19, 2026 | Increased |
KYMR — KYMERA THERAPEUTICS
501575104
|
Units/share: 0.01058 → 0.01064 (0.6%) |
| Aug. 19, 2026 | Increased |
KYTX — KYVERNA THERAPEUTICS
501976104
|
Units/share: 0.005574 → 0.005608 (0.6%) |
| Aug. 19, 2026 | Increased |
LAB — STANDARD BIOTOOLS
34385P108
|
Units/share: 0.05547 → 0.0558 (0.6%) |
| Aug. 19, 2026 | Increased |
LCTX — LINEAGE CELL THERAPEUTICS INC
53566P109
|
Units/share: 0.02769 → 0.02785 (0.6%) |
| Aug. 19, 2026 | Increased |
LEGN — LEGEND BIOTECH ADR REP
52490G102
|
Units/share: 0.02203 → 0.02216 (0.6%) |
| Aug. 19, 2026 | Increased |
LENZ — LENZ THERAPEUTICS
52635N103
|
Units/share: 0.004042 → 0.004066 (0.6%) |
| Aug. 19, 2026 | Increased |
LKFT — LAKEFRONT BIOTHERAPEUTICS ADR NV
36315X101
|
Units/share: 0.00619 → 0.006227 (0.6%) |
| Aug. 19, 2026 | Increased |
LRMR — LARIMAR THERAPEUTICS
517125100
|
Units/share: 0.00776 → 0.007806 (0.6%) |
| Aug. 19, 2026 | Increased |
LXEO — LEXEO THERAPEUTICS
52886X107
|
Units/share: 0.009111 → 0.009165 (0.6%) |
| Aug. 19, 2026 | Increased |
LYEL — LYELL IMMUNOPHARMA
55083R203
|
Units/share: 0.001133 → 0.00114 (0.6%) |
| Aug. 19, 2026 | Increased |
MAZE — MAZE THERAPEUTICS
578784100
|
Units/share: 0.005153 → 0.005184 (0.6%) |
| Aug. 19, 2026 | Increased |
MBX — MBX BIOSCIENCES
55287L101
|
Units/share: 0.004388 → 0.004414 (0.6%) |
| Aug. 19, 2026 | Increased |
MDGL — MADRIGAL PHARMACEUTICALS
558868105
|
Units/share: 0.003228 → 0.003247 (0.6%) |
| Aug. 19, 2026 | Increased |
MEDP — MEDPACE HOLDINGS
58506Q109
|
Units/share: 0.003423 → 0.003444 (0.6%) |
| Aug. 19, 2026 | Increased |
MENS — JYONG BIOTECH LTD
KYG831161065
|
Units/share: 0.004298 → 0.004324 (0.6%) |
| Aug. 19, 2026 | Increased |
MESO — MESOBLAST ADR REPRESENTING
590717401
|
Units/share: 0.01048 → 0.01054 (0.6%) |
| Aug. 19, 2026 | Increased |
MGTX — MEIRAGTX HOLDINGS PLC
KYG596651029
|
Units/share: 0.01051 → 0.01057 (0.6%) |
| Aug. 19, 2026 | Increased |
MIRM — MIRUM PHARMACEUTICALS
604749101
|
Units/share: 0.007373 → 0.007417 (0.6%) |
| Aug. 19, 2026 | Increased |
MLYS — MINERALYS THERAPEUTICS
603170101
|
Units/share: 0.009031 → 0.009085 (0.6%) |
| Aug. 19, 2026 | Increased |
MNKD — MANNKIND
56400P706
|
Units/share: 0.04397 → 0.04424 (0.6%) |
| Aug. 19, 2026 | Increased |
MRNA — MODERNA INC
60770K107
|
Units/share: 0.05406 → 0.05439 (0.6%) |
| Aug. 19, 2026 | Increased |
MRVI — MARAVAI LIFESCIENCES HOLDINGS INC
56600D107
|
Units/share: 0.01579 → 0.01588 (0.6%) |
| Aug. 19, 2026 | Increased |
MYGN — MYRIAD GENETICS
62855J104
|
Units/share: 0.01307 → 0.01314 (0.6%) |
| Aug. 19, 2026 | Increased |
NAMS — NEWAMSTERDAM PHARMA
NL00150012L7
|
Units/share: 0.01196 → 0.01203 (0.6%) |
| Aug. 19, 2026 | Increased |
NBIX — NEUROCRINE BIOSCIENCES
64125C109
|
Units/share: 0.0147 → 0.01479 (0.6%) |
| Aug. 19, 2026 | Increased |
NBP — NOVABRIDGE BIOSCIENCES ADR
44975P103
|
Units/share: 0.01238 → 0.01246 (0.6%) |
| Aug. 19, 2026 | Increased |
NGNE — NEUROGENE INC
64135M105
|
Units/share: 0.002358 → 0.002372 (0.6%) |
| Aug. 19, 2026 | Increased |
NMRA — NEUMORA THERAPEUTICS INC
640979100
|
Units/share: 0.01138 → 0.01145 (0.6%) |
| Aug. 19, 2026 | Increased |
NRIX — NURIX THERAPEUTICS INC
67080M103
|
Units/share: 0.01456 → 0.01465 (0.6%) |
| Aug. 19, 2026 | Increased |
NTLA — INTELLIA THERAPEUTICS
45826J105
|
Units/share: 0.01966 → 0.01978 (0.6%) |
| Aug. 19, 2026 | Increased |
NTRA — NATERA
632307104
|
Units/share: 0.02032 → 0.02044 (0.6%) |
| Aug. 19, 2026 | Increased |
NUVB — NUVATION BIO CLASS A
67080N101
|
Units/share: 0.03684 → 0.03706 (0.6%) |
| Aug. 19, 2026 | Increased |
NVAX — NOVAVAX
670002401
|
Units/share: 0.02326 → 0.0234 (0.6%) |
| Aug. 19, 2026 | Increased |
NVCR — NOVOCURE
JE00BYSS4X48
|
Units/share: 0.01552 → 0.01561 (0.6%) |
| Aug. 19, 2026 | Increased |
OABI — OMNIAB INC
68218J103
|
Units/share: 0.01734 → 0.01745 (0.6%) |
| Aug. 19, 2026 | Increased |
OLMA — OLEMA PHARMACEUTICALS
68062P106
|
Units/share: 0.01044 → 0.01051 (0.6%) |
| Aug. 19, 2026 | Increased |
ONC — BEONE MEDICINES AG
07725L102
|
Units/share: 0.01185 → 0.01192 (0.6%) |
| Aug. 19, 2026 | Increased |
OPK — OPKO HEALTH
68375N103
|
Units/share: 0.05573 → 0.05607 (0.6%) |
| Aug. 19, 2026 | Increased |
ORIC — ORIC PHARMACEUTICALS
68622P109
|
Units/share: 0.009195 → 0.00925 (0.6%) |
| Aug. 19, 2026 | Increased |
ORKA — ORUKA THERAPEUTICS INC
687604108
|
Units/share: 0.007544 → 0.007589 (0.6%) |
| Aug. 19, 2026 | Increased |
PACB — PACIFIC BIOSCIENCES OF CALIFORNIA
69404D108
|
Units/share: 0.04307 → 0.04333 (0.6%) |
| Aug. 19, 2026 | Increased |
PCVX — VAXCYTE
92243G108
|
Units/share: 0.021 → 0.02113 (0.6%) |
| Aug. 19, 2026 | Increased |
PEPG — PEPGEN
713317105
|
Units/share: 0.009393 → 0.009449 (0.6%) |
| Aug. 19, 2026 | Increased |
PGEN — PRECIGEN
74017N105
|
Units/share: 0.02339 → 0.02353 (0.6%) |
| Aug. 19, 2026 | Increased |
PHAT — PHATHOM PHARMACEUTICALS
71722W107
|
Units/share: 0.008406 → 0.008457 (0.6%) |
| Aug. 19, 2026 | Increased |
PHVS — PHARVARIS N V
NL00150005Y4
|
Units/share: 0.004341 → 0.004367 (0.6%) |
| Aug. 19, 2026 | Increased |
PRAX — PRAXIS PRECISION MEDICINES
74006W207
|
Units/share: 0.003884 → 0.003907 (0.6%) |
| Aug. 19, 2026 | Increased |
PRME — PRIME MEDICINE
74168J101
|
Units/share: 0.01403 → 0.01412 (0.6%) |
| Aug. 19, 2026 | Increased |
PRTA — PROTHENA PLC
IE00B91XRN20
|
Units/share: 0.006902 → 0.006943 (0.6%) |
| Aug. 19, 2026 | Increased |
PSNL — PERSONALIS
71535D106
|
Units/share: 0.009275 → 0.00933 (0.6%) |
| Aug. 19, 2026 | Increased |
PTCT — PTC THERAPEUTICS
69366J200
|
Units/share: 0.01192 → 0.01199 (0.6%) |
| Aug. 19, 2026 | Increased |
PTGX — PROTAGONIST THERAPEUTICS
74366E102
|
Units/share: 0.009077 → 0.009131 (0.6%) |
| Aug. 19, 2026 | Increased |
PYXS — PYXIS ONCOLOGY INC
747324101
|
Units/share: 0.007846 → 0.007893 (0.6%) |
| Aug. 19, 2026 | Increased |
QSI — QUANTUM SI INC CLASS A
74765K105
|
Units/share: 0.02509 → 0.02524 (0.6%) |
| Aug. 19, 2026 | Increased |
QTRX — QUANTERIX
74766Q101
|
Units/share: 0.005872 → 0.005908 (0.6%) |
| Aug. 19, 2026 | Increased |
QURE — UNIQURE
NL0010696654
|
Units/share: 0.008431 → 0.008481 (0.6%) |
| Aug. 19, 2026 | Increased |
RAPP — RAPPORT THERAPEUTICS
75383L102
|
Units/share: 0.004248 → 0.004274 (0.6%) |
| Aug. 19, 2026 | Increased |
RARE — ULTRAGENYX PHARMACEUTICAL
90400D108
|
Units/share: 0.01337 → 0.01345 (0.6%) |
| Aug. 19, 2026 | Increased |
RCKT — ROCKET PHARMACEUTICALS
77313F106
|
Units/share: 0.0153 → 0.01539 (0.6%) |
| Aug. 19, 2026 | Increased |
RCUS — ARCUS BIOSCIENCES
03969F109
|
Units/share: 0.01243 → 0.0125 (0.6%) |
| Aug. 19, 2026 | Increased |
REGN — REGENERON PHARMACEUTICALS
75886F107
|
Units/share: 0.01501 → 0.0151 (0.6%) |
| Aug. 19, 2026 | Increased |
REPL — REPLIMUNE GROUP
76029N106
|
Units/share: 0.01146 → 0.01153 (0.6%) |
| Aug. 19, 2026 | Increased |
RGEN — REPLIGEN
759916109
|
Units/share: 0.007938 → 0.007985 (0.6%) |
| Aug. 19, 2026 | Increased |
RGNX — REGENXBIO
75901B107
|
Units/share: 0.00875 → 0.008803 (0.6%) |
| Aug. 19, 2026 | Increased |
RIGL — RIGEL PHARMACEUTICALS
766559702
|
Units/share: 0.002687 → 0.002703 (0.6%) |
| Aug. 19, 2026 | Increased |
RLAY — RELAY THERAPEUTICS
75943R102
|
Units/share: 0.02442 → 0.02457 (0.6%) |
| Aug. 19, 2026 | Increased |
ROIV — ROIVANT SCIENCES LTD
BMG762791017
|
Units/share: 0.07682 → 0.07729 (0.6%) |
| Aug. 19, 2026 | Increased |
RVMD — REVOLUTION MEDICINES
76155X100
|
Units/share: 0.02833 → 0.0285 (0.6%) |
| Aug. 19, 2026 | Increased |
RXRX — RECURSION PHARMACEUTICALS CLASS A
75629V104
|
Units/share: 0.06989 → 0.0703 (0.6%) |
| Aug. 19, 2026 | Increased |
RYTM — RHYTHM PHARMACEUTICALS
76243J105
|
Units/share: 0.009871 → 0.00993 (0.6%) |
| Aug. 19, 2026 | Increased |
SANA — SANA BIOTECHNOLOGY
799566104
|
Units/share: 0.02673 → 0.02689 (0.6%) |
| Aug. 19, 2026 | Increased |
SEPN — SEPTERNA
81734D104
|
Units/share: 0.004094 → 0.004119 (0.6%) |
| Aug. 19, 2026 | Increased |
SGAFT — CASH COLLATERAL USD SGAFT
Xe4f63973721
|
Units/share: 0.003126 → 0.003183 (1.8%) |
| Aug. 19, 2026 | Increased |
SGMT — SAGIMET BIOSCIENCES SERIES A
786700104
|
Units/share: 0.008655 → 0.008707 (0.6%) |
| Aug. 19, 2026 | Increased |
SION — SIONNA THERAPEUTICS
829401108
|
Units/share: 0.00393 → 0.003953 (0.6%) |
| Aug. 19, 2026 | Increased |
SLDB — SOLID BIOSCIENCES INC
83422E204
|
Units/share: 0.01176 → 0.01183 (0.6%) |
| Aug. 19, 2026 | Increased |
SLN — SILENCE THERAPEUTICS ADR REPRESENT
82686Q101
|
Units/share: 0.00389 → 0.003913 (0.6%) |
Showing latest 200 of 5475 changes
Institutional owners (13F) 1,036 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| BNP PARIBAS FINANCIAL MARKETS | $421,829,818 | 9.50% | 2,217,939 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $302,042,070 | 6.80% | 1,588,107 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $221,873,575 | 5.00% | 1,166,589 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $213,518,446 | 4.81% | 1,122,659 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $169,085,529 | 3.81% | 889,035 | Shares | June 30, 2026 |
| PEAK6 LLC | $157,876,719 | 3.56% | 830,100 | Call option | June 30, 2026 |
| LPL Financial LLC | $150,135,091 | 3.38% | 789,395 | Shares | June 30, 2026 |
| COMMERCE BANK | $149,648,339 | 3.37% | 786,836 | Shares | June 30, 2026 |
| UBS Group AG | $141,457,236 | 3.19% | 743,768 | Shares | June 30, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $138,077,940 | 3.11% | 726,000 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $127,368,703 | 2.87% | 669,692 | Shares | June 30, 2026 |
| WestEnd Advisors, LLC | $124,744,693 | 2.81% | 655,852 | Shares | June 30, 2026 |
| BANK OF AMERICA CORP /DE/ | $100,538,047 | 2.26% | 528,619 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79,613,534 | 1.79% | 418,600 | Put option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68,886,818 | 1.55% | 362,200 | Call option | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $66,566,500 | 1.50% | 350,000 | Shares | June 30, 2026 |
| Jefferies Financial Group Inc. | $57,495,733 | 1.29% | 302,306 | Shares | June 30, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | $44,563,427 | 1.00% | 234,310 | Shares | June 30, 2026 |
| BARCLAYS PLC | $38,297,609 | 0.86% | 201,365 | Shares | June 30, 2026 |
| PNC Financial Services Group, Inc. | $38,000,913 | 0.86% | 199,805 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $31,096,065 | 0.70% | 163,500 | Call option | June 30, 2026 |
| STIFEL FINANCIAL CORP | $26,437,159 | 0.60% | 138,996 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $26,214,727 | 0.59% | 137,834 | Shares | June 30, 2026 |
| AMERIPRISE FINANCIAL INC | $24,642,402 | 0.55% | 128,884 | Shares | June 30, 2026 |
| Focus Partners Wealth | $24,013,121 | 0.54% | 126,258 | Shares | June 30, 2026 |
| ALBION FINANCIAL GROUP /UT | $22,753,461 | 0.51% | 119,635 | Shares | June 30, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | $22,083,912 | 0.50% | 116,115 | Shares | June 30, 2026 |
| Cetera Investment Advisers | $22,024,704 | 0.50% | 115,804 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $20,730,710 | 0.47% | 109,000 | Put option | June 30, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $19,368,569 | 0.44% | 101,838 | Shares | June 30, 2026 |
| Itau Unibanco Holding S.A. | $18,805,226 | 0.42% | 98,876 | Shares | June 30, 2026 |
| INVESTMENT HOUSE LLC | $18,394,226 | 0.41% | 96,715 | Shares | June 30, 2026 |
| ExodusPoint Capital Management, LP | $18,265,467 | 0.41% | 96,038 | Shares | June 30, 2026 |
| Erste Asset Management GmbH | $17,342,761 | 0.39% | 102,330 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $16,869,853 | 0.38% | 88,700 | Put option | June 30, 2026 |
| MML INVESTORS SERVICES, LLC | $16,284,678 | 0.37% | 85,623 | Shares | June 30, 2026 |
| ASSETMARK, INC | $16,221,132 | 0.37% | 85,289 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $16,095,532 | 0.36% | 84,570 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $15,614,599 | 0.35% | 82,100 | Call option | June 30, 2026 |
| MAI Capital Management | $15,522,282 | 0.35% | 81,615 | Shares | June 30, 2026 |
| FACTORY MUTUAL INSURANCE CO | $13,503,490 | 0.30% | 71,000 | Shares | June 30, 2026 |
| D. E. Shaw & Co., Inc. | $13,117,594 | 0.30% | 68,971 | Shares | June 30, 2026 |
| Bronte Capital Management Pty Ltd. | $12,515,833 | 0.28% | 65,807 | Shares | June 30, 2026 |
| CUMBERLAND ADVISORS INC | $12,175,583 | 0.27% | 64,018 | Shares | June 30, 2026 |
| NTV Asset Management LLC | $12,169,323 | 0.27% | 63,985 | Shares | June 30, 2026 |
| Beacon Pointe Advisors, LLC | $12,038,493 | 0.27% | 63,297 | Shares | June 30, 2026 |
| Tradition Wealth Management, LLC | $11,826,840 | 0.27% | 62,184 | Shares | June 30, 2026 |
| FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC | $11,607,345 | 0.26% | 61,030 | Shares | June 30, 2026 |
| Horizon Wealth Management, LLC | $11,465,582 | 0.26% | 60,285 | Shares | June 30, 2026 |
| Apella Capital, LLC | $11,404,083 | 0.26% | 57,530 | Shares | June 30, 2026 |
| Corient Private Wealth LP | $10,770,613 | 0.24% | 56,629 | Shares | June 30, 2026 |
| Pictet Asset Management Holding SA | $10,428,961 | 0.23% | 54,950 | Shares | June 30, 2026 |
| Parker Investment Management, LLC | $10,423,041 | 0.23% | 54,803 | Shares | June 30, 2026 |
| BROWN ADVISORY INC | $10,213,796 | 0.23% | 53,703 | Shares | June 30, 2026 |
| CAPITAL FUND MANAGEMENT S.A. | $10,107,647 | 0.23% | 53,145 | Shares | June 30, 2026 |
| Reyes Financial Architecture, Inc. | $10,058,198 | 0.23% | 52,885 | Shares | June 30, 2026 |
| Waverly Advisors, LLC | $9,987,833 | 0.22% | 52,515 | Shares | June 30, 2026 |
| MILLENNIUM MANAGEMENT LLC | $9,884,935 | 0.22% | 51,974 | Shares | June 30, 2026 |
| Sanctuary Advisors, LLC | $9,795,378 | 0.22% | 51,503 | Shares | June 30, 2026 |
| Humankind Investments LLC | $9,509,500 | 0.21% | 50,000 | Shares | June 30, 2026 |
| IFP Advisors, Inc | $9,507,218 | 0.21% | 49,988 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $9,190,076 | 0.21% | 48,321 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $8,991,803 | 0.20% | 47,278 | Shares | June 30, 2026 |
| Kestra Advisory Services, LLC | $8,975,993 | 0.20% | 47,195 | Shares | June 30, 2026 |
| Henshaw Capital LLC | $8,938,930 | 0.20% | 47,000 | Shares | June 30, 2026 |
| L & S Advisors Inc | $8,757,108 | 0.20% | 46,044 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $8,749,554 | 0.20% | 46,004 | Shares | June 30, 2026 |
| DAVENPORT & Co LLC | $8,615,552 | 0.19% | 45,300 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $8,288,262 | 0.19% | 58,200 | Put option | Sept. 30, 2025 |
| FORBES J M & CO LLP | $8,248,730 | 0.19% | 43,371 | Shares | June 30, 2026 |
| DAFNA Capital Management LLC | $8,101,143 | 0.18% | 42,595 | Shares | June 30, 2026 |
| TOTH FINANCIAL ADVISORY CORP | $8,037,702 | 0.18% | 42,261 | Shares | June 30, 2026 |
| SP Asset Management LLC | $7,838,297 | 0.18% | 41,213 | Shares | June 30, 2026 |
| Summit Financial, LLC | $7,552,142 | 0.17% | 39,708 | Shares | June 30, 2026 |
| MMBG INVESTMENT ADVISORS CO. | $7,158,181 | 0.16% | 37,637 | Shares | June 30, 2026 |
| EQUITABLE TRUST CO | $6,731,775 | 0.15% | 35,395 | Shares | June 30, 2026 |
| BEARING POINT CAPITAL, LLC | $6,714,468 | 0.15% | 35,304 | Shares | June 30, 2026 |
| Michelson Medical Research Foundation, Inc. | $6,674,718 | 0.15% | 35,095 | Shares | June 30, 2026 |
| Caption Management, LLC | $6,637,631 | 0.15% | 34,900 | Put option | June 30, 2026 |
| J. Goldman & Co LP | $6,637,631 | 0.15% | 34,900 | Put option | June 30, 2026 |
| Addison Capital Co | $6,542,048 | 0.15% | 34,397 | Shares | June 30, 2026 |
| Williams Jones Wealth Management, LLC. | $6,450,674 | 0.15% | 33,917 | Shares | June 30, 2026 |
| JONES FINANCIAL COMPANIES LLLP | $6,351,704 | 0.14% | 33,901 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $6,166,353 | 0.14% | 43,300 | Call option | Sept. 30, 2025 |
| Equitable Holdings, Inc. | $5,996,315 | 0.14% | 31,528 | Shares | June 30, 2026 |
| Colonial Trust Advisors | $5,970,421 | 0.13% | 31,392 | Shares | June 30, 2026 |
| McCollum Christoferson Group LLC | $5,881,436 | 0.13% | 30,924 | Shares | June 30, 2026 |
| Aristides Capital LLC | $5,782,917 | 0.13% | 30,406 | Shares | June 30, 2026 |
| Y-Intercept (Hong Kong) Ltd | $5,758,953 | 0.13% | 30,280 | Shares | June 30, 2026 |
| Mariner, LLC | $5,618,618 | 0.13% | 29,542 | Shares | June 30, 2026 |
| Volterra Technologies LP | $5,571,996 | 0.13% | 29,297 | Shares | June 30, 2026 |
| Caption Management, LLC | $5,553,548 | 0.13% | 29,200 | Call option | June 30, 2026 |
| SOUTHERN CAPITAL ADVISORS, LLC | $5,517,058 | 0.12% | 29,008 | Shares | June 30, 2026 |
| Howard Capital Management Group, LLC | $5,494,011 | 0.12% | 28,887 | Shares | June 30, 2026 |
| CMH Wealth Management LLC | $5,484,700 | 0.12% | 28,838 | Shares | June 30, 2026 |
| Crescent Grove Advisors, LLC | $5,443,300 | 0.12% | 28,620 | Shares | June 30, 2026 |
| Ashton Thomas Private Wealth, LLC | $5,335,590 | 0.12% | 28,054 | Shares | June 30, 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $5,334,446 | 0.12% | 29,848 | Shares | June 30, 2026 |
| Gladstone Institutional Advisory LLC | $5,245,758 | 0.12% | 27,582 | Shares | June 30, 2026 |
| FIFTH THIRD BANCORP | $5,221,717 | 0.12% | 27,456 | Shares | June 30, 2026 |
Peer funds
More from this issuer
Similar by size
| Fund | AUM |
|---|---|
| EWZ iShares, Inc. | $10.2B |
| VPU VANGUARD WORLD FUND | $10.6B |
| IGF iShares Trust | $10.6B |
| JIRE J.P. Morgan Exchange-Traded Fun… | $10.6B |
| IGM iShares Trust | $10.6B |
| PAAA PGIM ETF Trust | $10.2B |
| DFCF Dimensional ETF Trust | $10.1B |
| SCHH SCHWAB STRATEGIC TRUST | $10.0B |
| BUFR First Trust Exchange-Traded Fun… | $9.6B |
| FNDE SCHWAB STRATEGIC TRUST | $9.6B |